Next Article in Journal
Recognition Interface of the Thrombin Binding Aptamer Requires Antiparallel Topology of the Quadruplex Core
Next Article in Special Issue
Impact of Selenium on Biomarkers and Clinical Aspects Related to Ageing. A Review
Previous Article in Journal
The Iron Maiden. Cytosolic Aconitase/IRP1 Conformational Transition in the Regulation of Ferritin Translation and Iron Hemostasis
Previous Article in Special Issue
Systemic Copper Disorders Influence the Olfactory Function in Adult Rats: Roles of Altered Adult Neurogenesis and Neurochemical Imbalance
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

The Labile Iron Pool Reacts Rapidly and Catalytically with Peroxynitrite

by
André Luís Condeles
and
José Carlos Toledo Junior
*
Departamento de Química, Faculdade de Filosofia, Ciências e Letras de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto 14040-901, Brazil
*
Author to whom correspondence should be addressed.
Biomolecules 2021, 11(9), 1331; https://doi.org/10.3390/biom11091331
Submission received: 17 June 2021 / Revised: 27 July 2021 / Accepted: 28 July 2021 / Published: 9 September 2021
(This article belongs to the Special Issue Toxic and Essential Metals in Human Health and Disease 2021)

Abstract

:
While investigating peroxynitrite-dependent oxidation in murine RAW 264.7 macrophage cells, we observed that removal of the Labile Iron Pool (LIP) by chelation increases the intracellular oxidation of the fluorescent indicator H2DCF, so we concluded that the LIP reacts with peroxynitrite and decreases the yield of peroxynitrite-derived oxidants. This was a paradigm-shifting finding in LIP biochemistry and raised many questions. In this follow-up study, we address fundamental properties of the interaction between the LIP and peroxynitrite by using the same cellular model and fluorescence methodology. We have identified that the reaction between the LIP and peroxynitrite has catalytic characteristics, and we have estimated that the rate constant of the reaction is in the range of 106 to 107 M−1s−1. Together, these observations suggest that the LIP represents a constitutive peroxynitrite reductase system in RAW 264.7 cells.

1. Introduction

Iron can coordinate with different types and numbers of ligands to form compounds with different geometries, while reversibly adopting a few stable oxidation and spin states. Such versatility provides iron compounds with different structural and chemical properties, which allow them to engage in fundamentally distinct chemical reactions. In particular, iron-mediated redox reactions are central in numerous biological processes, from biosynthesis to catabolism and energy transduction [1]. The iron pool associated with these physiological functions is firmly and directly bound to proteins or incorporated into protein prosthetic cofactor groups such as heme and iron sulfur-clusters. In contrast, the so-called labile iron pool (LIP) is poorly characterized, but there is growing evidence that the LIP is also protein-bound.
The LIP is defined as the fraction of cellular iron that can be complexed with high-affinity metal chelators [1,2]. Depending on the cell type, the iron content of this pool accounts for 0.1 to 3% of the total cellular iron. Perturbations in the levels of the LIP trigger cellular iron homeostasis mechanisms involving complementary actions that work toward restoring the status of the LIP [3]. For example, a manipulated rise in the LIP in K562 cells was found to be transient and to dissipate within 30 min [4]. These observations indicated that the LIP is under tight cellular homeostatic control and is an essential cellular component [2,3,5]. Currently, the LIP is thought to be primarily present in the ferrous state [4] and serve as a dynamic cellular iron source readily available for incorporation into fresh apo-iron proteins [3]. On the other hand, the LIP is often associated with an elusive cellular iron source that can potentially damage metabolites, macromolecules, and macro-biological structures through reaction with hydrogen peroxide (H2O2), which produces oxidants such as the highly reactive hydroxyl radical (OH) [4,6]. This property is being explored as a potential cancer therapy [7,8]. Indeed, the LIP is often referred to as the redox toxic iron source developing from conditions such as iron overload, and it has been associated with hepatic [9,10,11] and cardiac [12,13] conditions and brain disorders [3,14,15,16]. Thus, the same redox activity that makes iron so physiologically useful may also be dangerous. The central importance of iron in biological systems, its intrinsic toxicity and elusive nature have motivated investigations into the chemical properties and reactivity of the LIP. Previously, our group [17] and others [18,19,20] showed that the LIP reacts with nitrogen monoxide (nitric oxide, NO), producing dinitrosyl iron complexes (DNICs) in RAW 264.7 cells, which are considered stable NO carriers. DNICs are potential nitrosylating agents and may directly transfer nitrosyl equivalents to protein cysteine residues via cross-trans-nitrosation reactions [18,21,22], which may be a selective mechanism of protein S-nitrosylation. More recently, we investigated the possible reaction between the LIP and peroxynitrite (ONOOH/ONOO; pKa = 6.9) in RAW 264.7 cells [23,24]. We selected the macrophage cell line as model for this study for several reasons: (i) macrophages cells are thought to be normally exposed to and to deal with peroxynitrite; (ii) macrophage cells are major players in the systemic iron homeostatic mechanism; (iii) macrophage cells normally carry larger concentrations of LIP. Peroxynitrite is formed by the diffusion-limited recombination reaction of ubiquitous NO and superoxide anion radicals ( O 2 ) (k1 = 1.9 × 1010 M−1s−1) [24]. In addition to being a strong oxidant, upon protonation or reaction with CO2, peroxynitrite generates highly reactive oxidant species such as OH, nitrogen dioxide ( NO 2 ) , and carbonate anion radicals ( CO 3 ) ) [25,26], which can damage various biological molecules and have been implicated in the onset of several pathological conditions [25,27].
Unlike the reaction between the LIP and H2O2, we previously demonstrated that the reaction between the LIP and peroxynitrite decreases the peroxynitrite-dependent intracellular oxidation and nitrosylation of fluorescent targets and protein carbonylation [23]. Inspired by the two-electron reduction of peroxynitrite by manganese (II) and iron (II) porphyrin complexes [28,29] as well as ferrous heme proteins [30,31,32], we hypothesized that the ferrous LIP directly reduces peroxynitrite to nitrite ( NO 2 ) (Scheme 1) [23], thereby detoxifying peroxynitrite. However, whether this reaction is rapid and stoichiometric or catalytic is unclear. In the present study, we address these fundamental questions. We will show that our results are consistent with a rapid and catalytic reaction between the LIP and peroxynitrite.

2. Materials and Methods

2.1. Chemicals

Unless specified otherwise, all the chemicals were purchased from Sigma-Aldrich (St. Louis, Missouri, USA) and were of the highest purity available. The chelator salicylaldehyde isonicotinoyl hydrazine (SIH) was synthesized through a Schiff base condensation reaction between 2-hydroxybenzaldehyde and isonicotinic acid hydrazide, as described previously (ref ponka). The nitric oxide donors and coumarin-7-boronic acid (CBA) were purchased from Cayman Chemical Co (Ann Arbor, MI, USA), and Calcein was acquired from Biotium (Fremont, CA, USA). All the stock solutions including the solutions of NO donors, Ebselen, hexacyanoferrate (II), ascorbate, and SIH were prepared, maintained, and quantified as described previously [23]. The stock solutions of paraquat were spectrophotometrically calibrated by measuring their absorbance at 600 nm (ε = 2.9 × 105 L mol−1 cm−1) after reduction with 1–10% of dithionite in 0.1 mol L−1 NaOH [33,34].

2.2. Cell Culture and Treatment

RAW 264.7 cells (ATCC) were incubated and cultured at 37 °C in Dulbecco’s Modified Eagle’s Medium supplemented with 100 units/mL penicillin, 100 μg/mL streptomycin-penicillin, and 10% fetal bovine serum (FBS). The cells were passaged, seeded onto 75 cm2 T-flask culture dishes, and grown overnight, to reach between 85% and 90% confluence. Then, the cells were washed with PBS/DTPA (100 µM) twice, harvested, and centrifuged at 450× g and 4 °C for 5 min. Finally, the cells were suspended in 10 mL of complete medium and incubated on ice. The trypan blue exclusion assay was conducted before and after the experiments, and cell viability ranged from 85% to 95%.

2.3. Quantification of the LIP

Briefly, a suspension of RAW 264.7 cells in PBS/DTPA (45 × 106 cell/mL) was treated with the aceto-methoxy derivatized calcein probe (Calcein-AM) (0.25, 0.5, 1.0, 2.0, and 3.0 μM) under constant stirring at 37 °C for 20 min, washed (two cycles of centrifugation and resuspension in ice-cold CA-free PBS), and kept on ice until use. Calcein-AM is cleaved by nonspecific esterases, forming the fluorescent product Calcein (CA), which can no longer freely cross biological membranes and accumulates intracellularly. At the time of the experiment, a suspension of Calcein-AM-loaded cells (15 × 106 cells in a total volume of 3.0 mL) was transferred to pre-warmed (37 °C) PBS/DTPA and placed in the fluorimeter, and data acquisition was initiated. The initial fluorescence is proportional to the intracellular concentration of free CA. Then, the high-affinity membrane-permeable iron chelator SIH was added with the help of a Hamilton syringe, and the fluorescence signal increased because CA was released (Figure 1A). This differential fluorescence recovery (ΔF) was proportional to the intracellular concentration of the CA-bound LIP. The concentrations of the solutions of free CA and the CA-bound LIP were determined by using a standard analytical curve of fluorescence versus concentration of free CA (Figure 1B inset), which was generated by successive additions of known concentrations of free CA to a suspension of control cells in the presence of SIH. The intracellular concentrations of free CA and the CA-bound LIP were calculated by unit conversion; the following equation was used: ((CA) or (LIP-bound CA-)) × assay total volume/total volume of cells (the diameter of RAW 264.7 cells is 7 μm, as reported elsewhere) [35]. The stock solution of CA was prepared in DMSO, and the concentration was determined by using the absorbance at 492 nm and the molar absorptivity coefficient of ε492 = 7.5 × 104 M−1 cm−1 (provided by Biotium). The total concentration of the LIP in the RAW 264.7 cells was assumed to be the limiting concentration of the CA-bound LIP.

2.4. Fluorescence Experiments

A suspension of RAW 264.7 cells in PBS/DTPA was loaded with 30 μM 2′,7′-dichlorodihydrofluorescein diacetate (H2DCF-DA; fluorescent indicator) under constant stirring at 37 °C for 30 min. To minimize differences in the intracellular concentrations of the fluorescent indicator during the experiments, the same number of cells was systematically used when the indicator was loaded (60 × 106 cells/mL). Once the indicator permeates biological membranes, the ester bonds present in H2DCF-DA are cleaved by non-specific esterases, and the product 2′,7′-dichlorodihydrofluorescein (H2DCF) is trapped and begins to accumulate intracellularly. To avoid the presence of extracellular H2DCF, the cells were subjected to two cycles of centrifugation and resuspension after the loading procedure. For the assays regarding H2DCF, the cells were transferred to 96-well plates (3 × 106 cells per pool in 250 μL), and the experiments were performed in a plate reader (Molecular Device SpectraMax i3x) with the following fluorescence acquisition parameter settings: λexcitation = 498 nm, λemission = 523 nm (H2DCF-DA), and excitation and emission slit widths of 9 and 15 nm, respectively. The CBA experiments were performed by using the same procedure, except that CBA (10 µM) was not loaded into the cells but simply included in the PBS/DTPA cellular suspension before the runs. COH and DCF fluorescence was measured at the time intervals designated in the figures. The donors sperNO and deta/NO were the NO sources in these experiments (these donors have half-lives of 39 min and 20 h at 37 °C and pH 7.4, respectively [36]) as described in the respective figure legends. All the experiments were performed in PBS buffer supplemented with 100 µM DTPA, and the temperature was controlled by a circulating water bath and/or the instrument internal temperature control (heated air flow) maintained at 37 °C.

2.5. In the Rate of Fluorescence Increase

The rates at which the intracellular fluorescence of COH and DCF increased were determined by linear regression analyses of the fluorescence data. See the respective figures for more details.

2.6. Statistical Analysis

All the measurements are presented as the means ± S.D. of n ≥ 3 experiments. The means were compared between groups by using an F test followed by a paired Student’s t-test; the academic version of the software Origin 2019 was employed (OriginLab Corporation, Northampton, MA, USA). p values of <0.05 were considered to be statistically significant.

3. Results

3.1. Quantifying the LIP

First, we evaluated the LIP content of RAW 264.7 cells by using a modified Calcein methodology [2]. Briefly, we pre-loaded a suspension of RAW 264.7 cells in PBS/DTPA (45 × 106 cell/mL) with the aceto-methoxy derivatized calcein probe (Calcein-AM). Calcein-AM is cleaved by nonspecific esterases, forming the fluorescent product Calcein (CA), which can no longer freely cross biological membranes and thus accumulates intracellularly. The intracellular fluorescence of CA is quenched when the LIP binds to its EDTA-like moiety in a 1:1 stoichiometry; the remaining initial fluorescence is proportional to the intracellular concentration of free CA (Figure 1A). When the high-affinity membrane-permeable iron chelator SIH is introduced, the fluorescence signal increases due to LIP and the chelator complexation and CA release (Figure 1A) [2,37]; the differential fluorescence recovery (ΔF) is proportional to the intracellular concentration of the CA-bound LIP. We determined the intracellular concentrations of the CA-bound LIP with increasing intracellular concentrations of free CA (Figure 1A) and fitted the data ((CA-bound LIP) × (free CA)) displayed in Figure 1B to a hyperbolic equation. We assumed that the total concentration of the LIP in RAW 264.7 cells was the limiting concentration of the CA-bound LIP, which was 2.0 ± 0.2 µM.

3.2. Checking Formation of Peroxynitrite

Next, we checked the formation of peroxynitrite in cells by co-production of NO and O 2 according to Scheme 1 [38]. We transferred a suspension of RAW 264.7 cells to 96-well plates and treated it with the NO donor (Z)-1-[N-[3-aminopropyl]-N-[4-(3-aminopropylammonio)butyl]-amino]diazen-1-ium-1,2-diolate (sperNO) and the redox cycler N,N′-dimethyl-4,4′-bipyridinium dichloride (paraquat), which catalytically generates intracellular O 2 at the expense of cellular reducing agents, Scheme 1. The combination of paraquat and sperNO is herein referred to as PQ/NO.
We followed the formation of peroxynitrite by PQ/NO in RAW 264.7 cells by fluorescence spectroscopy, by using 10 µM of the boronate compound coumarin-7-boronic acid (CBA). This compound reacts with peroxynitrite at a high rate constant (k = 1.1 × 106 M−1s−1) [39], producing the fluorescent product 7-hydroxy coumarin (COH). As shown in Figure 2, on the basis of the accumulated COH, treatment with PQ/NO produced peroxynitrite in cells in a sperNO concentration-dependent way at least up to 15 µM sperNO, showing no sign of O 2 exhaustion. This behavior was expected given that NO and cellular SODs compete for ( O 2 ) . We used the combination PQ/NO throughout the study to deliver peroxynitrite to cells.

3.3. Monitoring Peroxynitrite-Dependent Oxidation

Similarly to our previous study [23], we used 2′,7′-dichlorodihydrofluorescein diacetate (H2DCF-DA) to monitor peroxynitrite-dependent oxidation. We visualized that the LIP reacted with peroxynitrite by the incremental peroxynitrite-dependent oxidation of H2DCF-DA in the presence of the LIP chelator, which bound to the LIP and inhibited the reaction between the LIP and peroxynitrite. Using H2DCF for our purposes has several advantages. First, by using its diacetate form (H2DCF-DA), H2DCF can be loaded into cells (through action of nonspecific esterases) [23] and accumulates to hundreds of µM intracellularly. This is critical for our goals, given that H2DCF has to compete with multiple cellular targets for the peroxynitrite-derived radicals. In our hands, the intracellular concentration of H2DCF approached 400 µM in the typical cell loading procedure (Supplementary Material, Figure S1). Second, H2DCF does not react directly with the peroxynitrite precursors NO and O 2 or H2O2 (the product of O 2 dismutation). Third, H2DCF reacts with all peroxynitrite-derived radicals such as OH, NO 2 , and CO 3 at high rate constants. If we consider that GSH is the only competitor, we can calculate that 400 µM H2DCF reacts with 80% of CO 3 (assuming 5 mM GSH, kGSH = 5.3 × 106 M−1s−1, and kH2DCF = 2.6 × 108 M−1s−1) [40]. Similar calculations showed that H2DCF would react with only 5% of the NO 2 (kH2DCF = 1.3 × 107 M−1s−1) [40], but we confirmed that H2DCF efficiently (directly or indirectly) detected NO 2 (Please, see Figure 3 below). To guarantee that the oxidation of H2DCF depended on peroxynitrite as intermediate, we ran parallel control experiments in the presence of 2-phenyl-1,2-benzoselenazol-3-one (Ebselen), a compound that directly and rapidly reduces peroxynitrite to NO 2 (Equation (1)) [41]. Ebselen fully inhibited the intracellular oxidation of H2DCF by treatment with PQ/NO in both the absence and presence of the chelator (Please see Figure 3 and Figure 4 below), indicating that formation of dichloro-fluorescein (DCF) in the presence of PQ/NO depended on peroxynitrite acting as intermediate. In addition, along with proper controls, H2DCF has been used to detect peroxynitrite [42] and to determine fluxes of peroxynitrite in activated macrophages [38].
Ebselen + ONOO   k   =   1   ×   10 6   M - 1 s - 1   Selenide + NO 2
The mechanism through which H2DCF is oxidized deserves a final comment. Strong radical oxidant species such as those derived from peroxynitrite [40] or high-valent ferryl species derived from reactions of hydrogen peroxide with heme-proteins and heme-peroxidases (known as compound I and compound II) [40,43] oxidize H2DCF mono-electronically, yielding the putative radical DCFH. The latter may dismutate, but it more likely reduces O2 to O 2 , yielding the fluorescent product DCF in the process (supplementary information). Obviously, production of O 2 by this mechanism raises concerns because it could react with NO, to form peroxynitrite, potentially self-stimulating the peroxynitrite-dependent oxidation of H2DCF. However, the amount of O 2 (and thus H2O2) produced by this mechanism is arguably negligible compared to O 2 -derived paraquat. According to a rough estimation based on kinetic competition (Supplementary information), O 2 -derived H2DCF amounts to, at most, less than 6% of the O 2 -derived paraquat.
It could be argued that boronate compounds are a more appropriate choice of indicator to investigate the hypothetical reaction between the LIP and peroxynitrite because these compounds directly and rapidly react with peroxynitrite [44,45]. However, such approach poses difficulties. First, only a small fraction of the available peroxynitrite actually reacts with boronate in cells. In a similar cellular model, fluorescein-derived boronate (Fl-B) at a presumed concentration of 50 μM was estimated to react with only 10% of the available peroxynitrite. Moreover, possibly only a small fraction of available peroxynitrite (and even less in the presence of boronates) reacts with the LIP in cells given that the concentration of the LIP is in the low µM range. Rationally, in the presence of the LIP chelator, most peroxynitrite that would otherwise react with the LIP would not react with boronate but with other direct targets of peroxynitrite, such as TP and CO2 [46]. Thus, arguably, inhibition of the reaction between the LIP and peroxynitrite by the chelator would cause only a small and possibly experimentally undebatable increase in the peroxynitrite-dependent oxidation of boronate. We did not detect any increase in the oxidation of Fl-B in the presence of a chelator (not shown) in cells challenged with PQ/NO.

3.4. H2DCF Efficiently Detected Different Levels of NO 2 in Cells Regardless of the Presence of the Chelator SIH

To test whether H2DCF reacted with peroxynitrite-derived radicals under our experimental conditions, we had to design a strategy to deliver these species specifically to the cellular suspension model. We selected NO 2 as the prototype species. The NO 2 radical is a freely diffusible species that can rapidly access the cytosolic space [47,48], and it reacts rapidly with H2DCF (k = 1.3 × 107 M−1s−1) [40]. To the best of our knowledge, no currently available method can specifically deliver a continuous and sustained flux of the other peroxynitrite-derived species OH and CO 3 in the absence of other oxidants in cells. On the other hand, we generated increasing fluxes of NO 2 practically devoid of NO and other oxidants by mixing different concentrations of NO donor with excess 2-phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl 3-oxide (PTIO), an imidazoline-oxyl N-oxide that oxidizes NO to NO 2 [49,50,51,52,53,54] (Supplementary Material, Figure S2). We performed the experiment as follows. We placed H2DCF-loaded RAW 264.7 cells in 96-well plates and challenged them with sperNO in the presence of 250 µM PTIO, in the absence and in the presence of the chelator SIH (Figure 3A). As expected, compared to sperNO alone, PTIO, which fully oxidized NO to NO 2 , dramatically increased the rate at which DCF was formed. SIH had no effect on the H2DCF oxidation under these conditions. That NO 2 was the H2DCF oxidant in these experiments was confirmed by performing experiments in the presence of rapid NO 2 scavengers, hexacyanoferrate (II) (FCN) [55,56] and ascorbate (ASC) [57]. Neither FCN nor ASC reacts rapidly or at all with peroxynitrite, and both fully prevented the increase in DCF fluorescence induced by the combination of the NO donor and PTIO without any filter effect on the fluorescence of DCF (Figure 3B,C right panel). Therefore, H2DCF efficiently competed with other intracellular targets for NO 2 . In the experiments conducted with 15 µM sperNO, the rate at which the fluorescence increased slowed down toward the end of the run. The reason for this behavior was unclear, but it could involve exhaustion of H2DCF or further oxidation of the product DCF by NO 2 [43], although the rate constant for the reaction between DCF and NO 2 is two orders of magnitude lower than the reaction between DCF and the reduced PTIO.

3.5. Removal of the LIP by Chelation Increases Peroxynitrite-Dependent Intracellular Oxidation

We continued by repeating the critical experiments from our previous study, which had demonstrated augmented peroxynitrite-dependent intracellular oxidation of H2DCF upon chelation of the LIP in RAW 264.7 cells. We assessed the effect of the LIP by comparing the intracellular oxidation of H2DCF by PQ/NO with and without SIH, a cell membrane-permeable iron chelator that accesses the cytosolic space and binds to the LIP within a few minutes [2]. SIH is known for rapidly and strongly (Logβ2 = 26.9) binding ferrous iron in a 2:1 stoichiometry, yielding the (Fe(SIH)2) complex. This iron complex (Fe3+/Fe2+ redox pair at pH 7.4 is 0.13 V vs. NHE) does not undergo redox cycle to produce oxidants [58] and does not appear to react with peroxynitrite directly [23]. Direct oxidation of targets by peroxynitrite seems to take place by the inner-sphere mechanism [31,32,59], so metal chelators that prevent peroxynitrite binding are also likely to prevent the direct oxidation of transition metals by peroxynitrite.
To reproduce our previous experiments, we transferred a suspension of H2DCF-DA- loaded RAW 264.7 cells to 96-well plates and exposed it to peroxynitrite fluxes generated by PQ/NO as described above. As shown in Figure 4A, we recorded the fluorescence of DCF in real-time. We used the linear regression of the fluorescence data obtained during the first 10 min of each run to express these data as the rate of the increase in fluorescence, or the rate at which DCF was formed (Figure 4B). Importantly, the PQ/NO-induced oxidation of H2DCF was negligible in the absence of NO and was fully inhibited in experiments performed in the presence of Ebselen (Figure 4A,B). Together, these observations indicated that peroxynitrite mediated the formation of DCF in the presence of PQ/NO.
Consistent with our previous results [23], the rate at which DCF was formed increased significantly in the presence of SIH (Figure 4A,B), leading to the conclusion that LIP chelation increases the availability of peroxynitrite and its derived radical oxidants (Scheme 1). Importantly, in the absence of cells, SIH has no effect on peroxynitrite-dependent oxidation of H2DCF [23]. Together, these results lead to the conclusion that cellular SIH effect on peroxynitrite-dependent H2DCF oxidation is due to chelation of cellular LIP. In our previous study, we found that the cell membrane-permeable classic iron chelator 2,2′-bipyridine also elicits the chelator effect [23], indicating that this effect is not specific to SIH, but rather a common property of membrane-permeable LIP chelators. Finally, the oxidation of H2DCF and the enhanced effect of the chelators were also observed with endogenous NO produced by LPS-activated RAW 264.7 cells [23].
We estimated that the intracellular accumulation of DCF increased from 30 μM in the absence of SIH to 50 μM in the presence of SIH in the 60-min runs (Supplementary Material). This represented roughly 10% of the total intracellular concentration of H2DCF. It is also safe to assume that the total intracellular peroxynitrite produced during this time interval was at least 300 μM given that most peroxynitrite reacts with metalloproteins, thiol peroxidases, and other targets [46]. Given that LIP concentration in RAW 264.7 cells was 2 μM, LIP is the limiting species in its reactions with peroxynitrite.
Remarkably, Ebselen also fully prevented the formation of DCF in the presence of SIH, indicating that the oxidation of H2DCF in the presence of the chelator also depended on peroxynitrite. The fact that Ebselen (Figure 3C) and SIH (Figure 3A,C left panel) failed to affect the NO 2 -dependent oxidation of H2DCF excluded the possibility that NO autoxidation was an important source of NO 2 for the intracellular oxidation of H2DCF under our experimental conditions. Indeed, SIH and Ebselen can neither prevent the formation of NO 2 from NO autoxidation nor efficiently compete with H2DCF for NO 2 generated from NO and PTIO (PTIO is cell membrane-impermeable and thus generates NO 2 extracellularly, a compartment where both SIH and Ebselen may react with NO 2 , explaining why the oxidation of intracellular H2DCF is partially inhibited in the presence of SIH or Ebselen.) (Figure 3) as shown here. Together with the observations that SIH increased and Ebselen prevented the PQ/NO- induced oxidation of H2DCF, these results showed that the intracellular oxidants of H2DCF generated by treatment with PQ/NO primarily derived from peroxynitrite ([23]) under the study conditions. Finally, the fact that SIH failed to increase the formation of DCF in cells exposed to NO and PTIO (this failure does not mean that the LIP does not react with NO 2 ; it probably does react, but other NO 2 endogenous targets such as GSH (5–10mM) and exogenous targets such as H2DCF (400 µM) outcompete the LIP (2 µM) for NO 2 ) provided further evidence to refute the possibility that free SIH or the [Fe(SIH)2] complex somehow produces oxidants that would stimulate the formation of DCF inside the cells.
Other possibilities could explain the enhanced oxidation of H2DCF in the presence of SIH. However, extensive control experiments conducted in our previous study [23] showed that: (i) SIH and the [Fe(SIH)2] complex, which mimics the SIH/ferrous LIP, does not produce O 2 or other oxidants; (ii) neither the free SIH nor the [Fe(SIH)2] complex suppresses or interferes in the fluorescence properties of DCF; (iii) SIH does not interfere with the concentration of NO in cells; (iv) neither SIH nor the [Fe(SIH)2] complex appears to react with peroxynitrite directly; (v) significant H2O2-dependent oxidation of H2DCF did not happen under the experimental conditions of the study. Indeed, almost no DCF was formed in the absence of NO (indistinguishable from control experiments) and in the presence of PQ, a condition in which the availability of O 2 and H2O2 would be higher (Figure 4) [23]. This observation indicated that the chemistry of H2O2 with the LIP or iron peroxidases is not relevant for the intracellular oxidation of H2DCF under the study conditions. The chelator SIH also attenuates the H2O2-dependent oxidation of H2DCF [18] and increases the PQ/NO-dependent oxidation of H2DCF in RAW 264.7 cells (Figure 4) [23], indicating that the chemical mechanisms for the oxidation of H2DCF by H2O2 and PQ/NO in RAW 264.7 cells are fundamentally different; (vi) there is no reason to believe that SIH changes the concentrations of antioxidants in cells that prevent the formation of peroxynitrite (e.g., SODs) or that compete with H2DCF for peroxynitrite-derived radicals (e.g., GSH). The chelator enhancement effect is observed within seconds to few minutes after the chelator is introduced (please, see Figure 5A below), a time scale that is insufficient to affect the concentrations of the antioxidants. This time scale, however, is compatible with the kinetics of SIH cell membrane permeability and binding to the LIP (Figure 1A) [2,17]; (vii) H2DCF is oxidized in the presence of NO alone (in the absence of PQ), but this is possibly related to the formation of peroxynitrite by reaction of NO with endogenous O 2 since H2DCF was also inhibited by Ebselen (not shown).

3.6. Catalytic Properties of the Reaction between the LIP and Peroxynitrite

One important missing feature of the reaction between the LIP and peroxynitrite is whether it is stoichiometric or catalytic. We estimated that the concentration of the LIP in RAW 264.7 cells was 2 μM, and that at least 300 μM of peroxynitrite was formed in cells exposed to PQ/NO in the period of 60 min, so we concluded that the LIP was the limiting reactant of the reaction between the LIP and peroxynitrite under the experimental conditions of the study. We rationalized that if the reaction between the LIP and peroxynitrite were stoichiometric, the LIP would be gradually consumed by the reaction with peroxynitrite and thus its concentration would be reduced with delayed addition of SIH. In fact, we rationalized that the rate at which DCF is formed in the absence of the chelator would actually increase, approaching the rate at which DCF was generated in the presence of the chelator (labeled as 0 min in the Figure below). However, accumulated data [23,60] and results of the current study (Figure 4) showed that the rate at which DCF was formed in the absence of SIH was constant even at the highest concentration of NO donor used in the experiments. Assuming that the formation of peroxynitrite by PQ/NO was constant, as suggested by the CBA experiment (Figure 2), the concentration of the LIP form reactive toward peroxynitrite did not appreciably decrease over time, indicating that the LIP may catalytically remove peroxynitrite.
We tested the catalytic versus stoichiometric behavior of the reaction between the LIP and peroxynitrite by exposing the cells to peroxynitrite fluxes, as usual, but we introduced the chelator SIH at different time points during the experimental run (Figure 5A). Again, if the reaction between the LIP and peroxynitrite were stoichiometric, the SIH effect would gradually decrease due to consumption o LIP by peroxynitrite. However, as shown in Figure 5B, the rate at which the fluorescence increased after SIH was added remained unchanged regardless of the delay in the addition of SIH. Together, these observations suggested that the LIP catalytically reacts with peroxynitrite.

3.7. The Rate Constant of the Reaction between the LIP and Peroxynitrite

We estimated the rate constant for the hypothetical reaction between the LIP and peroxynitrite by using a rather simple reaction model (Equations (2)–(9)) for the rate of the peroxynitrite-dependent DCF formation, the parameter that we measure when we use the H2DCF assay in cells.
O 2 + SOD     k 2   O 2
NO + O 2   k 3     ONOO
ONOO + CO 2   k   4     0.35   ( NO 2 + CO 3 ) + 0.65   ( NO 3 + CO 2 )
ONOO + TP     k 5     OxTP   + NO 2
ONOO + LIP     k 6     LIP - Fe 4 + O + NO 2
R + CC     k 7     R   +   CC
R   +   H 2 DCF     k 8     R   +   DCFH
DCFH   +   O 2     k 9     O 2   +   DCF
The consumption of O 2 by SOD is simplified as the O 2 oxidase reaction (Equation (2)), and the formation of peroxynitrite is represented by the co-reaction between NO and O 2 Equation (3). Due to the inherent reactivity of peroxynitrite and its derived radicals, they can react with various cellular targets. All the direct reactions of peroxynitrite other than its reactions with CO2 Equation (4), k 4 = 3 × 104 M−1s−1 [61,62], and the LIP (Equation (6)) and all the reactions of the peroxynitrite-derived radicals other than their reaction with H2DCF Equation (8) are represented generically in Equations (5) and (7), respectively). In Equation (5), TP stands for thiol and iron peroxidases/proteins, and oxTP represents the oxidized form of these species. The constant k 5 represents an average weighted rate constant that depends on the concentration and reactivity of the TP members, which vary among cells (we assume these values range from 1 × 105 to 1 × 107 M−1s−1) [63,64]. In Equation (7), CC and CC stand for a collection of cell constituents that can be oxidized by peroxynitrite-derived radicals (such as GSH) and their corresponding oxidized forms. The peroxynitrite-derived radicals are represented collectively as R, and their corresponding reduced anions are represented as R (Equations (7) and (8)).
Assuming steady-state conditions for peroxynitrite and all the intermediate reactive species, our model demonstrated that the rate of the peroxynitrite-dependent indirect intracellular formation of DCF in the absence of the chelator is given by Equation (10) (see Supplementary Material for the demonstration of the equation).
d   [ DCF ] dt = 2 / 3   k 3   k 4   k 8 [ NO ] [ O 2 ] [ CO 2 ]   H 2 DCF ( k 4   [ CO 2 ]   +   k 5   [ TP ] + k 6   [ LIP ] )   ( k 7   CC   +   k 9 H 2 DCF )
The equation shows that the rate of the oxidation of H2DCF depends directly on the concentrations of NO   and   O 2 and indirectly on the concentration of TP, CC, and the LIP, while it has a complex relationship with the concentrations of CO2 and H2DCF. In the presence of the chelator, the rate of the oxidation of H2DCF is
d   [ DCF ] dt = 2 / 3   k 3   k 4   k 8 [ NO ] [ O 2 ] CO 2   H 2 DCF ( k 4   [ CO 2 ]   +   k 5   [ TP ] )   ( k 7   CC   +   k 9   H 2 DCF )
Because the term k6[LIP] vanishes from Equation (10).
Division of Equation (11) by Equation (10) and rearrangement gives an expression for k6 Equation (12), the rate constant for the hypothetical reaction between the LIP and peroxynitrite. This equation allows k6 to be estimated if all the other parameters (q, k4, k5, and the concentrations of CO2, TP, and LIP) are known. We determined the quotient (q), which represents a dimensionless parameter for the enhanced effect of the chelation of the LIP on the rate of the peroxynitrite-dependent indirect formation of DCF, experimentally. Using the data from Figure 5, we calculated the mean value of q as 1.7 (Figure 6). Whereas we did not measure the concentration of CO2 experimentally, its concentration in the aqueous phase of cellular suspensions under similar conditions (i.e., bicarbonate free buffer and open vessels) and experimental time scales suggest concentrations of CO2 in the range of hundreds of micromolar [65]. The concentration of TP varies depending on the cell type and cellular compartments. Considering only the thiol peroxidases, which are by far the most abundant TP members [66,67] and according to Wang et al. [68] and some calculations, TP concentration in several mammalian cell lines like Mus musculus and Raw 264.7 cells is around 10 μM. We determined that the concentration of the LIP in RAW 264.7 cells was 2.0 μM (Figure 1).
k 6 = ( q     1 )     k 4   CO 2 + k 5   [ TP ] [ LIP ]
Thus, assuming the concentrations of CO2 [65] and TP as 100 and 10 µM, respectively, as well as the lower and higher end limits of k5 (105–107 M−1s−1), we estimated the rate constant for the hypothetical reaction between peroxynitrite and the ferrous LIP to be between 1.4 × 106 M−1s−1 and 40 × 106 M−1s−1 in RAW 264.7 cells.
We recognize that our approach has several limitations and uncertainties. Nevertheless, we think that our assumptions are justified (please see below). In addition, the estimated range for the rate constant of the reaction between the ferrous LIP and peroxynitrite is comparable to the rate constants determined for similar reactions involving a two-electron oxidation of the ferrous ions of deoxymyoglobin [31,32] or myeloperoxidase [30] by peroxynitrite, for which k is in the order of 106 M−1s−1. The uncertainties of the model may include: (i) the fact that the model assumed that any other mechanism for the oxidation of H2DCF other than the mechanism mediated by peroxynitrite (through its derived radicals) are equal in the absence and presence of chelator. These may include the oxidation of H2DCF by reactions of H2O2 with iron proteins and with metallo-peroxidase. Under our experimental conditions, however, the formation of DCF fully depended on the availability of NO and could be prevented by the peroxynitrite scavenger Ebselen, so the H2O2-dependent formation of DCF was apparently not significant; (ii) similarly, our model assumed that the pathways for the consumption of O 2 (cellular SODs) and NO (cellular consumption of NOand autoxidation of NO) are equal in the absence and presence of chelator; (iii) the concentrations of TP and CO2 we used for the calculations are based on the literature, but given the simplicity of the model and the uncertainties above, determining these concentrations would not significantly increase the accuracy of the result; (iv) the model does not consider that the chelator itself is oxidized by the peroxynitrite-derived radicals and competes with H2DCF for these oxidants, which would have the practical effect of artefactually attenuating the incremental effect of the chelator on the rate at which DCF is formed.

4. Discussion

The nature of the cellular ferrous LIP remains unclear, but it is usually assumed to consist of small-molecular-mass iron complexes. On the basis of the available thermodynamic constants and concentrations, among all the bioavailable small molecular cellular ligands, only GSH could potentially serve as a meaningful ligand for the ferrous LIP in cells [69,70]. The reaction of GSH with either Fe(III) or Fe(II) ions in solution within the pH range of 3–7 yields the Fe(II)-GS complex only (excess GSH reduces ferric to ferrous iron), and empirical evidence supports the formation of Fe(II)-GS complexes in the cytosol [69,70]. However, we have hypothesized that the LIP is protein-bound by rationalizing that proteins potentially offer multiple ligands to iron [17], essentially functioning as metal chelator and forming species with higher thermodynamic affinity constants than GSH. This hypothesis is also based on the observation that iron in mononuclear non-heme enzymes such as prolyl hydroxylases (PHDs) are chelatable [71]. Additionally, a recent and convincing set of studies have strongly suggested that the LIP is bound to polyr(C)-binding protein 1 and 2 (PCBP1 and PCBP2) and possibly to other members of the PCBP family [72,73]. These proteins were initially characterized as RNA-binding proteins, but human PCBP1 and PCBP2 have been suggested to bind and to deliver iron to ferritin (the iron storage protein) [74], to deliver iron to cytosolic non-heme enzymes with mono- and di-nuclear iron centers such as prolyl hydroxylases and deoxy-hypusine hydroxylase (DOHH) [75,76], and to bind to mammalian protein BolA2, which together with gluta-redoxin 3 functions as (2Fe-2S) chaperones [72,73]. Conceptually, PCBP1 and PCBP2 have been suggested to be the LIP cellular ligands and major iron chaperones playing an integral roles in safe intracellular iron trafficking. The PCBP proteins are comprised of three discrete domains (called KH domains) [77]. Mutational analysis of the KH3 domain revealed that conserved cysteine and glutamate residues are necessary for PCBP1 to coordinate with iron [73]. Importantly, studies have shown that the purified recombinant PCBP1 KH3 binds Fe(II) with a dissociation constant of 4.2 and 0.8 μM in the absence and in the presence of 5 mM GSH, respectively [73], suggesting that GSH completes the coordination sphere of iron in PCBP proteins, reconciling the importance of GSH for the binding of the LIP in cells.
In this study, we focused on the fundamental properties of the reaction between peroxynitrite and the LIP in cells. Overall, the results presented herein indicate that the LIP directly, rapidly, and catalytically reacts with peroxynitrite in RAW 264.7 cells. Hypothetically, the ferrous LIP directly reduces peroxynitrite to nitrite (while it is oxidized to LIP-Fe=O4+), which presumably lowers the direct and indirect oxidation of cellular targets by peroxynitrite and its derived radicals. The reduction of LIP-Fe4+O back to the ferrous LIP would make the reduction of peroxynitrite by the LIP a catalytic process, which seems to be the case. The hypothetical LIP-Fe4+O reducing agent, the actual reactions, and the kinetic properties remain obscure, but given the possible PCBP1-GSH nature of the LIP, GSH seems to be a plausible candidate for the reduction of the LIP-Fe4+O species. Previous studies have demonstrated that the inhibition of the biosynthesis of GSH increases the oxidation of H2DCF [21] relative to the control in RAW 264.7 cells exposed to peroxynitrite, which is consistent with our hypothesis. However, these effects cannot be easily dissociated from direct scavenging of the peroxynitrite-derived oxidants by GSH. The depletion of GSH may also interfere in the PCBP-Fe(II) binding equilibrium and possibly with the reactivity of the LIP. Again, assuming the PCPB nature of LIP, it is also possible that protein amino acid residues act as the reducing agent for LIP-Fe4+O species. It is not unlikely that the Ferrous LIP and peroxynitrite reaction actually generates ferric LIP and NO 2 . Still, LIP could efficiently scavenge peroxynitrite anion while driving its oxidizing power into a single ferryl (LIP-Fe4+O) or radical ( NO 2 ) pathway, which could then be more effectively neutralized by cellular reductants such as GSH and maybe ASC [78]. Nonetheless, the catalytic characteristics combined with the rate constant estimated for the reaction between the LIP and peroxynitrite (k6 = 1.4–40 × 106 M−1s−1) suggest that the LIP may represent a relevant peroxynitrite reductase system in RAW 264.7 cells, efficiently competing with the reaction between peroxynitrite and CO2, which generates reactive radical oxidants. Given the ubiquity of LIP and that iron is a kinetic preferential target of peroxynitrite, it is tempting to conclude that the peroxynitrite and the LIP reaction is important in other cell types, especially in condition where peroxynitrite formation is likely such as infection and inflammation. However, this remains to be tested considering that the relevance of LIP at detoxifying peroxynitrite in cells depends on the concentration of the LIP itself and presumably on the activity of other peroxynitrite reductases systems that compete with the LIP for the oxidant, such as peroxiredoxins and glutathione peroxidases; the higher their concentration/activity the lower the LIP relevance (Equation (12)). Thus, the peroxynitrite reductase activity of LIP is probably cell type dependent.
The finding that the LIP attenuates the peroxynitrite-dependent oxidation apparently contradicts the documented pro-oxidant properties of the LIP. We extensively discussed this issue in our previous work [23]. It is important to point out again that the redox toxicity of the LIP is often rationalized in terms of its reaction with H2O2, and that the pro-oxidant outcome of such interaction is not a shared feature with other peroxides. Furthermore, the toxic iron that accumulates in chronic conditions such as Hemochromatosis, Thalassemia Major, and brain disorders or trauma, ferroptosis [79,80] and in acute iron loading does not necessarily represent the LIP and may have different chemical properties, including different reactivity toward H2O2 and peroxynitrite. Kakhlon et al. [81] showed that iron associated with the LIP in K562 cells only demonstrably increased the hydrogen peroxide-dependent oxidation of proteins when the LIP levels were manipulatively raised to at least 2.6-fold above its basal conditions, suggesting that LIP is not an oxidant while bound to its cellular ligand, but that the species binding to the LIP had limiting buffer capacity. The possible PCBP1 and other iron proteins nature of the LIP cannot be ignored, and it is not yet known how the expression of these proteins is affected under different conditions of iron overload. Thus, the relationship between the LIP and the toxic iron source that develops and accumulates under situations in which iron is dysregulated is not straightforward. Production of the oxyferryl oxidant species LIP-Fe4+O (Scheme 1, Equation (6)) by the hypothetical reaction between peroxynitrite and the LIP may also appear conflicting with our results. However, LIP-Fe4+ O is probably less reactive than peroxynitrite and its derived radical species. In addition, given the possible PCBP-GSH nature of the LIP, the LIP-Fe4+ O oxidative power may be neutralized by GSH.
One last point is worth discussing. We [17] and others [18] have shown that the LIP also reacts with NO. The competitive nature of the reaction of the LIP with NO and with peroxynitrite is not surprising given that this is a shared property of iron compounds and iron proteins. We reason that the reaction of the LIP with NO or peroxynitrite depend on the conditions, notably the availability of O 2 . Possibly, the formation of DNIC predominates under normal conditions, while the reaction between the LIP and peroxynitrite gains importance with increasing levels of O 2 given that the latter gradually outcompetes the LIP for NO. In addition, the reaction of the LIP with NO producing DNIC is rapid, but it is a complex multi-step process that requires at least two reversible NO binding steps and the reduction of Fe(II) to Fe(I) [22,82], which may limit the formation of DNIC. Interestingly, the formation of DNIC prevents the LIP- and H2O2-dependent oxidation of H2DCF in RAW 264.7 cells [18]. Thus, with regard to the chemistry related to NO and peroxynitrite, the LIP appears to exhibit complementary antioxidant activities under normal and oxidative conditions although this occurs through fundamentally different chemical mechanisms.

5. Conclusions

In summary, the LIP rapidly and possibly catalytically reacts with peroxynitrite. This reaction potentially attenuates the modifications made by peroxynitrite at biological targets, as we had shown in the case of protein carbonylation [23]. These findings broaden the conventional view of the reactivity of the LIP and have potential physiologically relevant implications in redox biology, particularly in infection and inflammation conditions when peroxynitrite is likely to be formed.

Supplementary Materials

The following are available online at https://www.mdpi.com/article/10.3390/biom11091331/s1, Quantification of total intracellular H2DCF (reduced) loaded into RAW264.7 cells upon treatment (Figure S1) and accumulated DCF after cell treatment with NO donor and paraquat. generation of fluxes of NO 2 (Figure S2), model for the oxidation of H2DCF by peroxynitrite-derived radical oxidants (Equations (S1)–(S25)).

Author Contributions

Conceptualization, J.C.T.J.; Methodology J.C.T.J. and A.L.C.; investigation, A.L.C.; writing—original draft preparation, J.C.T.J.; writing—review and editing, J.C.T.J. and A.L.C.; funding acquisition, J.C.T.J. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) Grant 2013/07937-8 and Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

References

  1. Ganz, T.; Nemeth, E. Iron homeostasis in host defence and inflammation. Nat. Rev. Immunol. 2015, 15, 500–510. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Epsztejn, S.; Kakhlon, O.; Glickstein, H.; Breuer, W.; Cabantchik, Z.I. Fluorescence analysis of the labile iron pool of mammalian cells. Anal. Biochem. 1997, 248, 31–40. [Google Scholar] [CrossRef]
  3. Rouault, T.A. The role of iron regulatory proteins in mammalian iron homeostasis and disease. Nat. Chem. Biol. 2006, 2, 406–414. [Google Scholar] [CrossRef]
  4. Breuer, W.; Epsztejn, S.; Cabantchik, Z.I. Dynamics of the cytosolic chelatable iron pool of K562 cells. FEBS Lett. 1996, 382, 304–308. [Google Scholar] [CrossRef] [Green Version]
  5. Camarena, V.; Huff, T.C.; Wang, G.F. Epigenomic regulation by labile iron. Free Radic. Biol. Med. 2021, 170, 44–49. [Google Scholar] [CrossRef]
  6. Kruszewski, M. Labile iron pool: The main determinant of cellular response to oxidative stress. Mutat. Res.-Fundam. Mol. Mech. Mutagenesis 2003, 531, 81–92. [Google Scholar] [CrossRef]
  7. Lin, L.S.; Wang, S.; Deng, H.Z.; Yang, W.J.; Rao, L.; Tian, R.; Liu, Y.; Yu, G.C.; Zhou, Z.J.; Song, J.B.; et al. Endogenous Labile Iron Pool-Mediated Free Radical Generation for Cancer Chemodynamic Therapy. J. Am. Chem. Soc. 2020, 142, 15320–15330. [Google Scholar] [CrossRef]
  8. Jiang, Z.Y.; Wang, Z.W.; Chen, L.; Zhang, C.; Liao, F.Y.; Wang, Y.W.; Wang, Y.; Luo, P.; Luo, M.; Shi, C.M. Artesunate induces ER-derived-ROS-mediated cell death by disrupting labile iron pool and iron redistribution in hepatocellular carcinoma cells. Am. J. Cancer Res. 2021, 11, 691. [Google Scholar]
  9. Golfeyz, S.; Lewis, S.; Weisberg, I.S. Hemochromatosis: Pathophysiology, evaluation, and management of hepatic iron overload with a focus on MRI. Expert Rev. Gastroenterol. Hepatol. 2018, 12, 767–778. [Google Scholar] [CrossRef]
  10. Kew, M.C. Hepatic Iron Overload and Hepatocellular Carcinoma. Liver Cancer 2014, 3, 31–40. [Google Scholar] [CrossRef]
  11. Miyanishi, K.; Tanaka, S.; Sakamoto, H.; Kato, J. The role of iron in hepatic inflammation and hepatocellular carcinoma. Free Radic. Biol. Med. 2019, 133, 200–205. [Google Scholar] [CrossRef] [PubMed]
  12. Chang, H.C.; Shapiro, J.S.; Ardehali, H. Getting to the “Heart” of Cardiac Disease by Decreasing Mitochondrial Iron. Circ. Res. 2016, 119, 1164–1166. [Google Scholar] [CrossRef] [Green Version]
  13. Siri-Angkul, N.; Chattipakorn, S.C.; Chattipakorn, N. Diagnosis and treatment of cardiac iron overload in transfusion-dependent thalassemia patients. Expert Rev. Hematol. 2018, 11, 471–479. [Google Scholar] [CrossRef] [PubMed]
  14. Lawen, A.; Lane, D.J.R. Mammalian Iron Homeostasis in Health and Disease: Uptake, Storage, Transport, and Molecular Mechanisms of Action. Antioxid. Redox Signal. 2013, 18, 2473–2507. [Google Scholar] [CrossRef]
  15. De Domenico, I.; Ward, D.M.; Kaplan, J. Regulation of iron acquisition and storage: Consequences for iron-linked disorders. Nat. Rev. Mol. Cell Biol. 2008, 9, 72–81. [Google Scholar] [CrossRef]
  16. Moos, T.; Morgan, E.H. The metabolism of neuronal iron and its pathogenic role in neurological disease—Review. Redox-Act. Met. Neurol. Disord. 2004, 1012, 14–26. [Google Scholar] [CrossRef]
  17. Toledo, J.C.; Bosworth, C.A.; Hennon, S.W.; Mahtani, H.A.; Bergonia, H.A.; Lancaster, J.R. Nitric Oxide-induced Conversion of Cellular Chelatable Iron into Macromolecule-bound Paramagnetic Dinitrosyliron Complexes. J. Biol. Chem. 2008, 283, 28926–28933. [Google Scholar] [CrossRef] [Green Version]
  18. Li, Q.; Li, C.Y.; Mahtani, H.K.; Du, J.; Patel, A.R.; Lancaster, J.R. Nitrosothiol Formation and Protection against Fenton Chemistry by Nitric Oxide-induced Dinitrosyliron Complex Formation from Anoxia-initiated Cellular Chelatable Iron Increase. J. Biol. Chem. 2014, 289, 19917–19927. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  19. Hickok, J.R.; Sahni, S.; Shen, H.; Arvind, A.; Antoniou, C.; Fung, L.W.M.; Thomas, D.D. Dinitrosyliron complexes are the most abundant nitric oxide-derived cellular adduct: Biological parameters of assembly and disappearance. Free Radic. Biol. Med. 2011, 51, 1558–1566. [Google Scholar] [CrossRef] [Green Version]
  20. Meczynska, S.; Lewandowska, H.; Sochanowicz, B.; Sadlo, J.; Kruszewski, M. Variable inhibitory effects on the formation of dinitrosyl iron complexes by deferoxamine and salicylaldehyde isonicotinoyl hydrazone in K562 cells. Hemoglobin 2008, 32, 157–163. [Google Scholar] [CrossRef] [PubMed]
  21. Bosworth, C.A.; Toledo, J.C.; Zmijewski, J.W.; Li, Q.; Lancaster, J.R. Dinitrosyliron complexes and the mechanism(s) of cellular protein nitrosothiol formation from nitric oxide. Proc. Natl. Acad. Sci. USA 2009, 106, 4671–4676. [Google Scholar] [CrossRef] [Green Version]
  22. Truzzi, D.R.; Augusto, O.; Ford, P.C. Thiyl radicals are co-products of dinitrosyl iron complex (DNIC) formation. Chem. Commun. 2019, 55, 9156–9159. [Google Scholar] [CrossRef] [PubMed]
  23. Damasceno, F.C.; Condeles, A.L.; Lopes, A.K.B.; Facci, R.R.; Linares, E.; Truzzi, D.R.; Augusto, O.; Toledo, J.C. The labile iron pool attenuates peroxynitrite-dependent damage and can no longer be considered solely a pro-oxidative cellular iron source. J. Biol. Chem. 2018, 293, 8530–8542. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Kissner, R.; Nauser, T.; Bugnon, P.; Lye, P.G.; Koppenol, W.H. Formation and properties of peroxynitrite as studied by laser flash photolysis, high-pressure stopped-flow technique, and pulse radiolysis. Chem. Res. Toxicol. 1997, 10, 1285–1292. [Google Scholar] [CrossRef]
  25. Beckman, J.S.; Beckman, T.W.; Chen, J.; Marshall, P.A.; Freeman, B.A. Apparent hydroxyl radical production by peroxynitrite—Implications for endothelial injury from nitric-oxide and superoxide. Proc. Natl. Acad. Sci. USA 1990, 87, 1620–1624. [Google Scholar] [CrossRef] [Green Version]
  26. Bonini, M.G.; Radi, R.; Ferrer-Sueta, G.; Ferreira, A.M.D.; Augusto, O. Direct EPR detection of the carbonate radical anion produced from peroxynitrite and carbon dioxide. J. Biol. Chem. 1999, 274, 10802–10806. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  27. Pacher, P.; Beckman, J.S.; Liaudet, L. Nitric oxide and peroxynitrite in health and disease. Physiol. Rev. 2007, 87, 315–424. [Google Scholar] [CrossRef] [Green Version]
  28. Shimanovich, R.; Groves, J.T. Mechanisms of peroxynitrite decomposition catalyzed by FeTMPS, a bioactive sulfonated iron porphyrin. Arch. Biochem. Biophys. 2001, 387, 307–317. [Google Scholar] [CrossRef]
  29. Ferrer-Sueta, G.; Batinic-Haberle, I.; Spasojevic, I.; Fridovich, I.; Radi, R. Catalytic scavenging of peroxynitrite by isomeric Mn(III) N-methylpyridylporphyrins in the presence of reductants. Chem. Res. Toxicol. 1999, 12, 442–449. [Google Scholar] [CrossRef]
  30. Furtmuller, P.G.; Jantschko, W.; Zederbauer, M.; Schwanninger, M.; Jakopitsch, C.; Herold, S.; Koppenol, W.H.; Obinger, C. Peroxynitrite efficiently mediates the interconversion of redox intermediates of myeloperoxidase. Biochem. Biophys. Res. Commun. 2005, 337, 944–954. [Google Scholar] [CrossRef]
  31. Exner, M.; Herold, S. Kinetic and mechanistic studies of the peroxynitrite-mediated oxidation of oxymyoglobin and oxyhemoglobin. Chem. Res. Toxicol. 2000, 13, 287–293. [Google Scholar] [CrossRef] [PubMed]
  32. Herold, S.; Exner, M.; Boccini, F. The mechanism of the peroxynitrite-mediated oxidation of myoglobin in the absence and presence of carbon dioxide. Chem. Res. Toxicol. 2003, 16, 390–402. [Google Scholar] [CrossRef] [PubMed]
  33. Rai, M.K.; Das, J.V.; Gupta, V.K. A sensitive determination of paraquat by spectrophotometry. Talanta 1997, 45, 343–348. [Google Scholar] [CrossRef]
  34. Calderbank, A.; Yuen, S.H. An Ion-Exchange Method for Determining Paraquat Residues in Food Crops. Analyst 1965, 90, 99–106. [Google Scholar] [CrossRef]
  35. Bakalar, M.H.; Joffe, A.M.; Schmid, E.M.; Son, S.; Podolski, M.; Fletcher, D.A. Size-Dependent Segregation Controls Macrophage Phagocytosis of Antibody-Opsonized Targets. Cell 2018, 174, 131–142.e13. [Google Scholar] [CrossRef] [Green Version]
  36. Li, Q.; Lancaster, J.R. Calibration of nitric oxide flux generation from diazeniumdiolate (NO)-N-center dot donors. Nitric Oxide-Biol. Chem. 2009, 21, 69–75. [Google Scholar] [CrossRef]
  37. Kakhlon, O.; Cabantchik, Z.I. The labile iron pool: Characterization, measurement, and participation in cellular processes. Free Radic. Biol. Med. 2002, 33, 1037–1046. [Google Scholar] [CrossRef]
  38. Alvarez, M.N.; Trujillo, M.; Radi, R. Peroxynitrite formation from biochemical and cellular fluxes of nitric oxide and superoxide. Methods Enzymol. 2002, 359, 353–366. [Google Scholar]
  39. Zielonka, J.; Sikora, A.; Joseph, J.; Kalyanaraman, B. Peroxynitrite Is the Major Species Formed from Different Flux Ratios of Co-generated Nitric Oxide and Superoxide: Direct reaction with boronate-based fluorescent probe. J. Biol. Chem. 2010, 285, 14210–14216. [Google Scholar] [CrossRef] [Green Version]
  40. Wrona, M.; Patel, K.; Wardman, P. Reactivity of 2′,7′-dichlorodihydrofluorescein and dihydrorhodamine 123 and their oxidized forms toward carbonated nitrogen dioxide, and hydroxyl radicals. Free Radic. Biol. Med. 2005, 38, 262–270. [Google Scholar] [CrossRef]
  41. Masumoto, K.; Kissner, R.; Koppenol, W.H.; Sies, H. Kinetic study of the reaction of ebselen with peroxynitrite. FEBS Lett. 1996, 398, 179–182. [Google Scholar] [CrossRef] [Green Version]
  42. Possel, H.; Noack, H.; Augustin, W.; Keilhoff, G.; Wolf, G. 2,7-Dihydrodichlorofluorescein diacetate as a fluorescent marker for peroxynitrite formation. FEBS Lett. 1997, 416, 175–178. [Google Scholar] [CrossRef] [Green Version]
  43. Wardman, P. Fluorescent and luminescent probes for measurement of oxidative and nitrosative species in cells and tissues: Progress, pitfalls, and prospects. Free Radic. Biol. Med. 2007, 43, 995–1022. [Google Scholar] [CrossRef]
  44. Sikora, A.; Zielonka, J.; Joseph, J.; Kalyanaraman, B. Oxidation of Coumarin Boronate to Hydroxycoumarin by Different Fluxes of Nitric Oxide and Superoxide: Quantitative Measurements of Peroxynitrite under Various Nitric Oxide Superoxide Fluxes. Free Radic. Biol. Med. 2009, 47, S36. [Google Scholar]
  45. Sikora, A.; Zielonka, J.; Lopez, M.; Dybala-Defratyka, A.; Joseph, J.; Marcinek, A.; Kalyanaraman, B. Reaction between Peroxynitrite and Boronates: EPR Spin-Trapping, HPLC Analyses, and Quantum Mechanical Study of the Free Radical Pathway. Chem. Res. Toxicol. 2011, 24, 687–697. [Google Scholar] [CrossRef] [Green Version]
  46. Rios, N.; Piacenza, L.; Trujillo, M.; Martinez, A.; Demicheli, V.; Prolo, C.; Alvarez, M.N.; Lopez, G.V.; Radi, R. Sensitive detection and estimation of cell-derived peroxynitrite fluxes using fluorescein-boronate. Free Radic. Biol. Med. 2016, 101, 284–295. [Google Scholar] [CrossRef] [PubMed]
  47. Squadrito, G.L.; Postlethwait, E.M. On the hydrophobicity of nitrogen dioxide: Could there be a "lens" effect for NO2 reaction kinetics? Nitric Oxide-Biol. Chem. 2009, 21, 104–109. [Google Scholar] [CrossRef] [Green Version]
  48. Signorelli, S.; Moller, M.N.; Coitino, E.L.; Denicola, A. Nitrogen dioxide solubility and permeation in lipid membranes. Arch. Biochem. Biophys. 2011, 512, 190–196. [Google Scholar] [CrossRef] [PubMed]
  49. Akaike, T.; Yoshida, M.; Miyamoto, Y.; Sato, K.; Kohno, M.; Sasamoto, K.; Miyazaki, K.; Ueda, S.; Maeda, H. Antagonistic action of Imidazolineoxyl N-oxides against endothelium-derived relaxing factor No through a radical reaction. Biochemistry 1993, 32, 827–832. [Google Scholar] [CrossRef] [PubMed]
  50. Akaike, T.; Maeda, H. Direct quantitation of nitric oxide released from cells using liposome-encapsulated PTIO. In Proceedings of the 4th International Meeting on the Biology of Nitric Oxide, Amelia Island, FL, USA, September 1995; p. 171. [Google Scholar]
  51. Goldstein, S.; Russo, A.; Samuni, A. Reactions of PTIO and carboxy-PTIO with (NO)-N-center dot, (NO2)-N-center dot, and O-2(center dot). J. Biol. Chem. 2003, 278, 50949–50955. [Google Scholar] [CrossRef] [Green Version]
  52. Espey, M.G.; Thomas, D.D.; Miranda, K.M.; Wink, D.A. Focusing of nitric oxide mediated nitrosation and oxidative nitrosylation as a consequence of reaction with superoxide. Proc. Natl. Acad. Sci. USA 2002, 99, 11127–11132. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  53. Kojima, H.; Nakatsubo, N.; Kikuchi, K.; Kawahara, S.; Kirino, Y.; Nagoshi, H.; Hirata, Y.; Nagano, T. Detection and imaging of nitric oxide with novel fluorescent indicators: Diaminofluoresceins. Anal. Chem. 1998, 70, 2446–2453. [Google Scholar] [CrossRef] [PubMed]
  54. Espey, M.G.; Miranda, K.M.; Thomas, D.D.; Wink, D.A. Distinction between nitrosating mechanisms within human cells and aqueous solution. J. Biol. Chem. 2001, 276, 30085–30091. [Google Scholar] [CrossRef] [Green Version]
  55. Goldstein, S.; Czapski, G. Indirect oxidation of ferrocyanide by peroxynitrite—Evidence against the formation of hydroxyl radicals. Nitric Oxide-Biol. Chem. 1997, 1, 417–422. [Google Scholar] [CrossRef] [PubMed]
  56. Forni, L.G.; Moraarellano, V.O.; Packer, J.E.; Willson, R.L. Nitrogen-dioxide and related free-radicals—electron-transfer reactions with organic-compounds in solutions containing nitrite or nitrate. J. Chem. Soc.-Perkin Trans. 2 1986, 1–6. [Google Scholar] [CrossRef]
  57. Kirsch, M.; de Groot, H. Ascorbate is a potent antioxidant against peroxynitrite-induced oxidation reactions—Evidence that ascorbate acts by re-reducing substrate radicals produced by peroxynitrite. J. Biol. Chem. 2000, 275, 16702–16708. [Google Scholar] [CrossRef] [Green Version]
  58. Chen, Y.L.; Kong, X.L.; Xie, Y.Y.; Hider, R.C. The interaction of pyridoxal isonicotinoyl hydrazone (PIH) and salicylaldehyde isonicotinoyl hydrazone (SIH) with iron. J. Inorg. Biochem. 2018, 180, 194–203. [Google Scholar] [CrossRef] [Green Version]
  59. Herold, S.; Koppenol, W.H. Peroxynitritometal complexes. Coord. Chem. Rev. 2005, 249, 499–506. [Google Scholar] [CrossRef]
  60. Damasceno, F.C.; Facci, R.R.; da Silva, T.M.; Toledo, J.C. Mechanisms and kinetic profiles of superoxide-stimulated nitrosative processes in cells using a diaminofluorescein probe. Free Radic. Biol. Med. 2014, 77, 270–280. [Google Scholar] [CrossRef] [Green Version]
  61. Denicola, A.; Freeman, B.A.; Trujillo, M.; Radi, R. Peroxynitrite reaction with carbon dioxide/bicarbonate: Kinetics and influence on peroxynitrite-mediated oxidations. Arch. Biochem. Biophys. 1996, 333, 49–58. [Google Scholar] [CrossRef]
  62. Lymar, S.V.; Hurst, J.K. Rapid reaction between peroxonitrite ion and carbon-dioxide—implications for biological-activity. J. Am. Chem. Soc. 1995, 117, 8867–8868. [Google Scholar] [CrossRef]
  63. Ogusucu, R.; Rettori, D.; Munhoz, D.C.; Netto, L.E.S.; Augusto, O. Reactions of yeast thioredoxin peroxidases I and II with hydrogen peroxide and peroxynitrite: Rate constants by competitive kinetics. Free Radic. Biol. Med. 2007, 42, 326–334. [Google Scholar] [CrossRef] [PubMed]
  64. Trujillo, M.; Ferrer-Sueta, G.; Radi, R. Kinetic studies on peroxynitrite reduction by peroxiredoxins. In Nitric Oxide, Pt G: Oxidative and Nitrosative Stress in Redox Regulation of Cell Signaling; Cadenas, E., Packer, L., Eds.; Methods in Enzymology; Elsevier Academic Press Inc: San Diego, CA, USA, 2008; Volume 441, pp. 173–196. [Google Scholar]
  65. Yang, Y.S.; Balcarcel, R.R. Determination of carbon dioxide production rates for mammalian cells in 24-well plates. Biotechniques 2004, 36, 286–295. [Google Scholar] [CrossRef]
  66. Ferrer-Sueta, G.; Manta, B.; Botti, H.; Radi, R.; Trujillo, M.; Denicola, A. Factors Affecting Protein Thiol Reactivity and Specificity in Peroxide Reduction. Chem. Res. Toxicol. 2011, 24, 434–450. [Google Scholar] [CrossRef]
  67. Milo, R. What is the total number of protein molecules per cell volume? A call to rethink some published values. Bioessays 2013, 35, 1050–1055. [Google Scholar] [CrossRef] [Green Version]
  68. Wang, M.C.; Herrmann, C.J.; Simonovic, M.; Szklarczyk, D.; von Mering, C. Version 4.0 of PaxDb: Protein abundance data, integrated across model organisms, tissues, and cell-lines. Proteomics 2015, 15, 3163–3168. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  69. Hamed, M.Y.; Silver, J. Studies on the reactions of ferric iron with glutathione and some related thiols II. Complex-formation in the pH range 3 to 7. Inorg. Chim. Acta-Bioinorg. Chem. 1983, 80, 115–122. [Google Scholar] [CrossRef]
  70. Hider, R.C.; Kong, X.L. Glutathione: A key component of the cytoplasmic labile iron pool. Biometals 2011, 24, 1179–1187. [Google Scholar] [CrossRef]
  71. Cho, E.A.; Song, H.K.; Lee, S.H.; Chung, B.H.; Lim, H.M.; Lee, M.K. Differential in vitro and cellular effects of iron chelators for hypoxia inducible factor hydroxylases. J. Cell. Biochem. 2013, 114, 864–873. [Google Scholar] [CrossRef]
  72. Philpott, C.C.; Patel, S.J.; Protchenko, O. Management versus miscues in the cytosolic labile iron pool: The varied functions of iron chaperones. Biochim. Biophys. Acta-Mol. Cell Res. 2020, 1867, 9. [Google Scholar] [CrossRef]
  73. Patel, S.J.; Frey, A.G.; Palenchar, D.J.; Achar, S.; Bullough, K.Z.; Vashisht, A.; Wohlschlegel, J.A.; Philpott, C.C. A PCBP1-BolA2 chaperone complex delivers iron for cytosolic 2Fe-2S cluster assembly. Nat. Chem. Biol. 2019, 15, 872–881. [Google Scholar] [CrossRef]
  74. Shi, H.F.; Bencze, K.Z.; Stemmler, T.L.; Philpott, C.C. A cytosolic iron chaperone that delivers iron to ferritin. Science 2008, 320, 1207–1210. [Google Scholar] [CrossRef] [Green Version]
  75. Nandal, A.; Ruiz, J.C.; Subramanian, P.; Ghimire-Rijal, S.; Sinnamon, R.A.; Stemmler, T.L.; Bruick, R.K.; Philpott, C.C. Activation of the HIF Prolyl Hydroxylase by the Iron Chaperones PCBP1 and PCBP2. Cell Metab. 2011, 14, 647–657. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  76. Frey, A.G.; Nandal, A.; Park, J.H.; Smith, P.M.; Yabe, T.; Ryu, M.S.; Ghosh, M.C.; Lee, J.; Rouault, T.A.; Park, M.H.; et al. Iron chaperones PCBP1 and PCBP2 mediate the metallation of the dinuclear iron enzyme deoxyhypusine hydroxylase. Proc. Natl. Acad. Sci. USA 2014, 111, 8031–8036. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  77. Leffers, H.; Dejgaard, K.; Celis, J.E. Characterization of 2 major cellular poly(rc)-binding human proteins, each containing 3 k-homologous (kh) domains. Eur. J. Biochem. 1995, 230, 447–453. [Google Scholar] [CrossRef]
  78. Zhou, L.F.; Zhang, L.X.; Wang, S.H.; Zhao, B.; Lv, H.H.; Shang, P. Labile iron affects pharmacological ascorbate-induced toxicity in osteosarcoma cell lines. Free Radic. Res. 2020, 54, 385–396. [Google Scholar] [CrossRef] [PubMed]
  79. Nishizawa, H.; Matsumoto, M.; Shindo, T.; Saigusa, D.; Kato, H.; Suzuki, K.; Sato, M.; Ishii, Y.; Shimokawa, H.; Igarashi, K. Ferroptosis is controlled by the coordinated transcriptional regulation of glutathione and labile iron metabolism by the transcription factor BACH1. J. Biol. Chem. 2020, 295, 69–82. [Google Scholar] [CrossRef] [PubMed]
  80. Zhang, C.P.; Liu, Z.X.; Zhang, Y.H.; Ma, L.; Song, E.Q.; Song, Y. “Iron free” zinc oxide nanoparticles with ion-leaking properties disrupt intracellular ROS and iron homeostasis to induce ferroptosis. Cell Death Dis. 2020, 11, 15. [Google Scholar] [CrossRef]
  81. Kakhlon, O.; Gruenbaum, Y.; Cabantchik, Z.L. Repression of ferritin expression increases the labile iron pool, oxidative stress, and short-term growth of human erythroleukemia cells. Blood 2001, 97, 2863–2871. [Google Scholar] [CrossRef] [Green Version]
  82. Pereira, J.C.M.; Iretskii, A.V.; Han, R.M.; Ford, P.C. Dinitrosyl Iron Complexes with Cysteine. Kinetics Studies of the Formation and Reactions of DNICs in Aqueous Solution. J. Am. Chem. Soc. 2015, 137, 328–336. [Google Scholar] [CrossRef] [Green Version]
Scheme 1. The cellular study model and the hypothetical reaction of the LIP with peroxynitrite. Peroxynitrite is delivered intracellularly by co-production of O 2 through paraquat (PQ) and NO (NO donor). Peroxynitrite reacts directly with thiol peroxidases, metalloproteins (TP) and CO2, phenomenologically producing 2/3 of NO 3 and CO2 and 1/3 of the oxidant radicals NO 2 and CO 3 . The acid-catalyzed decomposition of peroxynitrite phenomenologically produces 2/3 of NO 3 and 1/3 of the oxidant radicals NO 2 and OH, but it is kinetically less favorable and has been omitted for simplicity. Hypothesis: The ferrous LIP (LIPFe2+) directly reacts with peroxynitrite, presumably producing NO 2 . This reaction is inhibited by chelation of the LIP, which increases the availability of peroxynitrite and the net yield of peroxynitrite-derived radicals NO 2 and CO 3 , enhancing the peroxynitrite-dependent direct and indirect oxidation of cellular targets.
Scheme 1. The cellular study model and the hypothetical reaction of the LIP with peroxynitrite. Peroxynitrite is delivered intracellularly by co-production of O 2 through paraquat (PQ) and NO (NO donor). Peroxynitrite reacts directly with thiol peroxidases, metalloproteins (TP) and CO2, phenomenologically producing 2/3 of NO 3 and CO2 and 1/3 of the oxidant radicals NO 2 and CO 3 . The acid-catalyzed decomposition of peroxynitrite phenomenologically produces 2/3 of NO 3 and 1/3 of the oxidant radicals NO 2 and OH, but it is kinetically less favorable and has been omitted for simplicity. Hypothesis: The ferrous LIP (LIPFe2+) directly reacts with peroxynitrite, presumably producing NO 2 . This reaction is inhibited by chelation of the LIP, which increases the availability of peroxynitrite and the net yield of peroxynitrite-derived radicals NO 2 and CO 3 , enhancing the peroxynitrite-dependent direct and indirect oxidation of cellular targets.
Biomolecules 11 01331 sch001
Figure 1. Quantification of the LIP in RAW 264.7 cells. (A). Fluorescence trace of Calcein-AM-loaded RAW 264.7 cells upon introduction of SIH. Pre-warmed 3-mL suspensions of 15 × 106 cells previously treated with Calcein-AM (0.25, 0.5, 1.0, 2.0, or 3.0 µM) at 37 °C for 20 min were placed in the fluorimeter. When the baseline was established, SIH (100 µM) was added, as designated in the plot. The conditions and fluorescence acquisition parameter settings were as follows: PBS, 100 µM DTPA, pH 7.4, T = 37 °C, λex = 495 nm, λem = 516 nm, ex and em slit width = 3 nm. (B). Intracellular concentration of the CA-bound LIP as a function of the intracellular concentration of free CA. The concentration of the LIP was taken as the limiting concentration of the CA-bound LIP and was determined by fitting the data of Figure 1A to a hyperbolic equation with the aid of Origin 2019 (Academic), OriginLab Corporation, Northampton, MA, USA. The intracellular concentrations of free CA and the CA-bound LIP were determined by unit transformation; the concentrations of the solutions of CA and the CA-bound LIP were determined with the help of a standard analytical curve of fluorescence versus known concentrations of free CA (inset) in control Calcein-AM untreated cells (15 × 106 cells in 3 mL) and in the presence of SIH under the same conditions of the experiments. The CA assays were performed in a conventional spectrofluorometer (Shimadzu RF-5301pc).
Figure 1. Quantification of the LIP in RAW 264.7 cells. (A). Fluorescence trace of Calcein-AM-loaded RAW 264.7 cells upon introduction of SIH. Pre-warmed 3-mL suspensions of 15 × 106 cells previously treated with Calcein-AM (0.25, 0.5, 1.0, 2.0, or 3.0 µM) at 37 °C for 20 min were placed in the fluorimeter. When the baseline was established, SIH (100 µM) was added, as designated in the plot. The conditions and fluorescence acquisition parameter settings were as follows: PBS, 100 µM DTPA, pH 7.4, T = 37 °C, λex = 495 nm, λem = 516 nm, ex and em slit width = 3 nm. (B). Intracellular concentration of the CA-bound LIP as a function of the intracellular concentration of free CA. The concentration of the LIP was taken as the limiting concentration of the CA-bound LIP and was determined by fitting the data of Figure 1A to a hyperbolic equation with the aid of Origin 2019 (Academic), OriginLab Corporation, Northampton, MA, USA. The intracellular concentrations of free CA and the CA-bound LIP were determined by unit transformation; the concentrations of the solutions of CA and the CA-bound LIP were determined with the help of a standard analytical curve of fluorescence versus known concentrations of free CA (inset) in control Calcein-AM untreated cells (15 × 106 cells in 3 mL) and in the presence of SIH under the same conditions of the experiments. The CA assays were performed in a conventional spectrofluorometer (Shimadzu RF-5301pc).
Biomolecules 11 01331 g001
Figure 2. Formation of peroxynitrite by paraquat and NO donor in cells. Briefly, suspensions of RAW 264.7 cells were transferred to 96-well plates (1.2 × 107 cells/mL). CBA (10 μM), paraquat (10 μM), and sperNO (2, 5 or 15 µM) were individually added to selected wells, in this order. (A). COH fluorescence as a function of time. The measurements were initiated immediately after sperNO was introduced, and the fluorescence was registered every minute for one hour. The data represent the mean ± SD (n = 4). (B). Increase in the rate of COH fluorescence. This parameter was determined by linear regression of the fluorescence data presented in panel A within the first 10 min of each run. The data represent the mean of four independent experiments ± S.D. and are statistically significant at the 95% confidence interval relative to control cells * (p < 0.05, Paired Student’s t-test). The assays were performed in PBS, DTPA (100 µM), at pH 7.4 and 37 °C, and the fluorescence acquisition parameters were λex = 332 nm, λem = 456 nm, and ex and em slit width = 9 and 15 nm, respectively.
Figure 2. Formation of peroxynitrite by paraquat and NO donor in cells. Briefly, suspensions of RAW 264.7 cells were transferred to 96-well plates (1.2 × 107 cells/mL). CBA (10 μM), paraquat (10 μM), and sperNO (2, 5 or 15 µM) were individually added to selected wells, in this order. (A). COH fluorescence as a function of time. The measurements were initiated immediately after sperNO was introduced, and the fluorescence was registered every minute for one hour. The data represent the mean ± SD (n = 4). (B). Increase in the rate of COH fluorescence. This parameter was determined by linear regression of the fluorescence data presented in panel A within the first 10 min of each run. The data represent the mean of four independent experiments ± S.D. and are statistically significant at the 95% confidence interval relative to control cells * (p < 0.05, Paired Student’s t-test). The assays were performed in PBS, DTPA (100 µM), at pH 7.4 and 37 °C, and the fluorescence acquisition parameters were λex = 332 nm, λem = 456 nm, and ex and em slit width = 9 and 15 nm, respectively.
Biomolecules 11 01331 g002
Figure 3. NO 2 -dependent intracellular oxidation of H2DCF and the effects of SIH and Ebselen. A suspension of H2DCF-loaded RAW 264.7 cells was transferred to 96-well plates (1.2 × 107 cells/mL) and treated with sperNO (2 or 15 μM) in the presence of PTIO (250 μM) plus or minus SIH (100 µM). (A). Fluorescence traces of the oxidation of H2DCF by NO 2 generated by combination of sperNO and PTIO; (B). Fluorescence traces of the oxidation of H2DCF by NO 2 generated by combination of sperNO and PTIO in the presence of the NO 2 scavenger potassium hexacyanoferrate (II) [55] or ascorbate (100 μM). The data in panels A and B represent the mean ± S.D of three experiments and are statistically significant at the 95% confidence interval relative to control cells * (p < 0.05, Paired Student’s t-test); (C). Rate of the NO 2 -dependent intracellular oxidation of H2DCF shown in (A) and (B). The data represent the mean of three independent experiments ±S.D. The assays were performed in PBS and DTPA (100 μM), at pH 7.4, and 37 °C, and the fluorescence acquisition parameters were λex = 498 nm, λem = 523 nm, and ex and em slit width = 9 and 15 nm, respectively.
Figure 3. NO 2 -dependent intracellular oxidation of H2DCF and the effects of SIH and Ebselen. A suspension of H2DCF-loaded RAW 264.7 cells was transferred to 96-well plates (1.2 × 107 cells/mL) and treated with sperNO (2 or 15 μM) in the presence of PTIO (250 μM) plus or minus SIH (100 µM). (A). Fluorescence traces of the oxidation of H2DCF by NO 2 generated by combination of sperNO and PTIO; (B). Fluorescence traces of the oxidation of H2DCF by NO 2 generated by combination of sperNO and PTIO in the presence of the NO 2 scavenger potassium hexacyanoferrate (II) [55] or ascorbate (100 μM). The data in panels A and B represent the mean ± S.D of three experiments and are statistically significant at the 95% confidence interval relative to control cells * (p < 0.05, Paired Student’s t-test); (C). Rate of the NO 2 -dependent intracellular oxidation of H2DCF shown in (A) and (B). The data represent the mean of three independent experiments ±S.D. The assays were performed in PBS and DTPA (100 μM), at pH 7.4, and 37 °C, and the fluorescence acquisition parameters were λex = 498 nm, λem = 523 nm, and ex and em slit width = 9 and 15 nm, respectively.
Biomolecules 11 01331 g003
Figure 4. Sequestration of the LIP by chelation increases the peroxynitrite-dependent intracellular oxidation of H2DCF. (A) Fluorescence traces of the formation of DCF in cells treated with PQ/NO in the presence and absence of Ebselen and SIH; Briefly, H2DCF-loaded RAW 264.7 cells were transferred to 96-well plates (1.2 × 107 cells/mL). Paraquat (10 μM), SIH (100 μM), and Ebselen (50 μM) were individually added to selected wells in this order. The fluorescence measurements were initiated immediately after sperNO (15 μM) was introduced and registered every minute for one hour. Each trace represents the mean ± standard deviation (S.D.) of four experiments. (B) The rate at which the fluorescence of DCF increased. This parameter was determined by linear regression of the fluorescence data presented in panel A, by using the data collected during the first 10 min of each run. The data represent the mean of four independent experiments ± S.D. and are statistically significant at the 95% confidence interval relative to control cells * (p < 0.05, Paired Student’s t-test). The assays were performed in PBS and DTPA (100 μM), at pH 7.4, and 37 °C. The conditions and fluorescence acquisition and parameter settings were the same as those described in Figure 3.
Figure 4. Sequestration of the LIP by chelation increases the peroxynitrite-dependent intracellular oxidation of H2DCF. (A) Fluorescence traces of the formation of DCF in cells treated with PQ/NO in the presence and absence of Ebselen and SIH; Briefly, H2DCF-loaded RAW 264.7 cells were transferred to 96-well plates (1.2 × 107 cells/mL). Paraquat (10 μM), SIH (100 μM), and Ebselen (50 μM) were individually added to selected wells in this order. The fluorescence measurements were initiated immediately after sperNO (15 μM) was introduced and registered every minute for one hour. Each trace represents the mean ± standard deviation (S.D.) of four experiments. (B) The rate at which the fluorescence of DCF increased. This parameter was determined by linear regression of the fluorescence data presented in panel A, by using the data collected during the first 10 min of each run. The data represent the mean of four independent experiments ± S.D. and are statistically significant at the 95% confidence interval relative to control cells * (p < 0.05, Paired Student’s t-test). The assays were performed in PBS and DTPA (100 μM), at pH 7.4, and 37 °C. The conditions and fluorescence acquisition and parameter settings were the same as those described in Figure 3.
Biomolecules 11 01331 g004
Figure 5. The rate of intracellular oxidation of H2DCF as a function of the time when SIH was added. (A). Fluorescence traces due to the formation of DCF. The experiments were performed as described in Figure 4; 2,2′-(hydroxy-nitroso-hydrazono)bis-ethanimine (Deta/NO) was used as NO donor in the presence of paraquat. SIH was added before or at selected time points during the run, as designated in the figure. Deta/NO has a long half-life under the experimental conditions, producing a constant flux of NO in the time scale of the experiments. The data represent the mean ± S.D. of four experiments; (B). The rate at which the fluorescence increased after SIH was introduced. The rate was determined by linear regression of the fluorescence traces in the final 5 min of the collected data. The data represent the mean of four independent experiments ± S.D. The conditions and fluorescence acquisition and parameter settings were the same as those described in Figure 3.
Figure 5. The rate of intracellular oxidation of H2DCF as a function of the time when SIH was added. (A). Fluorescence traces due to the formation of DCF. The experiments were performed as described in Figure 4; 2,2′-(hydroxy-nitroso-hydrazono)bis-ethanimine (Deta/NO) was used as NO donor in the presence of paraquat. SIH was added before or at selected time points during the run, as designated in the figure. Deta/NO has a long half-life under the experimental conditions, producing a constant flux of NO in the time scale of the experiments. The data represent the mean ± S.D. of four experiments; (B). The rate at which the fluorescence increased after SIH was introduced. The rate was determined by linear regression of the fluorescence traces in the final 5 min of the collected data. The data represent the mean of four independent experiments ± S.D. The conditions and fluorescence acquisition and parameter settings were the same as those described in Figure 3.
Biomolecules 11 01331 g005
Figure 6. The quotient of the rates of fluorescence increased in the presence and absence of SIH. The quotient (q) was determined by dividing the rates of the increase in fluorescence in the presence of SIH by the rates of the increase in fluorescence in the absence of SIH; the data from Figure 5 were used.
Figure 6. The quotient of the rates of fluorescence increased in the presence and absence of SIH. The quotient (q) was determined by dividing the rates of the increase in fluorescence in the presence of SIH by the rates of the increase in fluorescence in the absence of SIH; the data from Figure 5 were used.
Biomolecules 11 01331 g006
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Condeles, A.L.; Toledo Junior, J.C. The Labile Iron Pool Reacts Rapidly and Catalytically with Peroxynitrite. Biomolecules 2021, 11, 1331. https://doi.org/10.3390/biom11091331

AMA Style

Condeles AL, Toledo Junior JC. The Labile Iron Pool Reacts Rapidly and Catalytically with Peroxynitrite. Biomolecules. 2021; 11(9):1331. https://doi.org/10.3390/biom11091331

Chicago/Turabian Style

Condeles, André Luís, and José Carlos Toledo Junior. 2021. "The Labile Iron Pool Reacts Rapidly and Catalytically with Peroxynitrite" Biomolecules 11, no. 9: 1331. https://doi.org/10.3390/biom11091331

APA Style

Condeles, A. L., & Toledo Junior, J. C. (2021). The Labile Iron Pool Reacts Rapidly and Catalytically with Peroxynitrite. Biomolecules, 11(9), 1331. https://doi.org/10.3390/biom11091331

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop